Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -48.61% is 29% above its 5-year average of -68.03%, near the high end of its 5-year range (-165.90%–-24.52%).
As of the fiscal period ended Tuesday, June 30, 2026. 56.55% above its 12-month average of -111.89%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -48.61%.
RETURN ON INVESTED CAPITAL (ROIC)
-48.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-111.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-86.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-68.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-36.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+56.55%
CURRENT VS 3Y AVG
+43.96%
CURRENT VS 5Y AVG
+28.54%
CURRENT VS 10Y AVG
-32.47%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-36.38%
vs the sector median at left
Editas Medicine, Inc.
Market Cap
$420.49M
Return on Invested Capital (ROIC)
-48.61%
TTM Avg
-111.89%
3Y Avg
-86.74%
5Y Avg
-68.03%
Market Cap
$418.67M
Return on Invested Capital (ROIC)
-71.22%
TTM Avg
-79.15%
3Y Avg
-65.81%
5Y Avg
-107.73%
Market Cap
$418.56M
Return on Invested Capital (ROIC)
-21.36%
TTM Avg
-47.45%
3Y Avg
-35.84%
5Y Avg
-28.07%
Market Cap
$424.96M
Return on Invested Capital (ROIC)
-2.98%
TTM Avg
-62.76%
3Y Avg
-40.63%
5Y Avg
-28.06%
Market Cap
$425.02M
Return on Invested Capital (ROIC)
-114.65%
TTM Avg
-31.55%
3Y Avg
-26.30%
5Y Avg
-23.63%
Market Cap
$412.06M
Return on Invested Capital (ROIC)
-69.35%
TTM Avg
-52.27%
3Y Avg
-73.46%
5Y Avg
-73.46%
Market Cap
$428.33M
Return on Invested Capital (ROIC)
-41.88%
TTM Avg
-37.25%
3Y Avg
-52.62%
5Y Avg
-51.87%
Market Cap
$429.18M
Return on Invested Capital (ROIC)
-5.29%
TTM Avg
-5.58%
3Y Avg
-6.88%
5Y Avg
-5.95%
Market Cap
$408.84M
Return on Invested Capital (ROIC)
-7.11%
TTM Avg
-10.90%
3Y Avg
-16.50%
5Y Avg
-14.69%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | $420.49M | -48.61% | -111.89% | -86.74% | -68.03% |
| Senseonics Holdings, Inc. (SENS)vs › | $418.67M | -71.22% | -79.15% | -65.81% | -107.73% |
| Prothena Corporation plc (PRTA)vs › | $418.56M | -21.36% | -47.45% | -35.84% | -28.07% |
| Tilray Brands, Inc. (TLRY)vs › | $424.96M | -2.98% | -62.76% | -40.63% | -28.06% |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $425.02M | -114.65% | -31.55% | -26.30% | -23.63% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $412.06M | -69.35% | -52.27% | -73.46% | -73.46% |
| Tectonic Therapeutic, Inc. (TECX)vs › | $428.33M | -41.88% | -37.25% | -52.62% | -51.87% |
| NeoGenomics, Inc. (NEO)vs › | $429.18M | -5.29% | -5.58% | -6.88% | -5.95% |
| Strata Critical Medical, Inc. (SRTA)vs › | $408.84M | -7.11% | -10.90% | -16.50% | -14.69% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $408.21M | -46.16% | -62.80% | -62.80% | -62.80% |
ROIC
-48.6%
ROE
-70.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -48.61% |
| 2026-03-31 | -93.01% |
| 2025-12-31 | -109.88% |
| 2025-09-30 | -142.06% |
| 2025-06-30 | -165.90% |
| 2025-03-31 | -136.63% |
| 2024-12-31 | -95.00% |
| 2024-09-30 | -89.54% |
| 2024-06-30 | -68.61% |
| 2024-03-31 | -49.54% |
| 2023-12-31 | -37.77% |
| 2023-09-30 | -46.78% |
| 2023-06-30 | -44.32% |
| 2023-03-31 | -55.57% |
| 2022-12-31 | -49.75% |
| 2022-09-30 | -41.76% |
| 2022-06-30 | -34.14% |
| 2022-03-31 | -31.88% |
| 2021-12-31 | -30.63% |
| 2021-09-30 | -32.64% |
| 2021-06-30 | -24.52% |
| 2021-03-31 | -20.26% |
| 2020-12-31 | -26.21% |
| 2020-09-30 | -19.99% |
| 2020-06-30 | -25.87% |
| 2020-03-31 | -38.73% |
| 2019-12-31 | -31.39% |
| 2019-09-30 | -41.81% |
| 2019-06-30 | -38.70% |
| 2019-03-31 | -33.57% |
| 2018-12-31 | -29.58% |
| 2018-09-30 | -34.27% |
| 2018-06-30 | -36.37% |
| 2018-03-31 | -32.40% |
| 2017-12-31 | -34.86% |
| 2017-09-30 | -39.56% |
| 2017-06-30 | -34.88% |
| 2017-03-31 | -30.57% |
| 2016-12-31 | -47.16% |
| 2016-09-30 | -30.90% |
| 2016-06-30 | -24.08% |
| 2016-03-31 | -20.11% |
| 2015-12-31 | -24.79% |
| 2015-09-30 | -18.18% |
| 2015-06-30 | -58.90% |
| 2014-12-31 | -208.78% |
